Michel Krempf - Concepedia

Author

Michel Krempf

Also Known As

Anne-Laure Fournier-Guilloux, Antonio Gallo, B Stuart, E Kraegen, Emile Ferrari, Khalifé Khalife, Krempf, M, Krempf, M., Krempf, M. (Michel), Krempf, Michel

527

Publications

19.5K

Citations

H-Index

180

Concepts

All Affiliations

Inserm Nantes Université Centre de Recherche en Nutrition Humaine Rhône-Alpes Centre Hospitalier Universitaire de Nantes Centre National de la Recherche Scientifique

About

Michel Krempf is an author at Inserm specializing in medicine, metabolic syndrome, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	74	8.7K
2	Health Sciences	24	29	2.8K
3	Engineering	4	4	93
4	Education	3	3	51
5	Natural Sciences	2	2	87

Michel Krempf

162

Publications

17.9K

Citations

H-Index

Page 1

	Year	Citations
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia Marianne Abifadel, Mathilde Varret, Jean‐Pierre Rabès, Nature Genetics Genetic DisorderGeneticsPathologyHyperlipidemiaMedicine	2003	3K
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management F. Xavier Pi‐Sunyer, Arne Astrup, Ken Fujioka, New England Journal of Medicine	2015	2.4K
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events Jennifer G. Robinson, Michel Farnier, Michel Krempf, New England Journal of Medicine	2015	2.3K
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients Lars Sjöström, Aila Rissanen, Teis Andersen, The Lancet ObesityMetabolic SyndromeNutritionWeight RegainLifestyle Modification	1998	1.2K
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial Carel W. le Roux, Arne Astrup, Ken Fujioka, The Lancet ObesityMetabolic SyndromeNutritionDiabetes ManagementLiraglutide Versus Placebo	2017	813
ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia John J.P. Kastelein, Henry N. Ginsberg, Gisle Langslet, European Heart Journal	2015	530
Hepatic PCSK9 Expression Is Regulated by Nutritional Status via Insulin and Sterol Regulatory Element-binding Protein 1c Philippe Costet, Bertrand Cariou, Gilles Lambert, Journal of Biological Chemistry ImmunologyCardiovascular AccidentsHyperlipidemiaFatty Liver DiseaseNutritional Status	2006	294
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial Ioanna Gouni‐Berthold, Veronica J. Alexander, Qingqing Yang, The Lancet Diabetes & Endocrinology PharmacologyPharmacotherapyMedicineMultifactorial Chylomicronaemia	2021	211
Novel mutations of thePCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia Delphine Allard, Sabine Amsellem, Marianne Abifadel, Human Mutation	2005	183
Apolipoprotein B100 Metabolism in Autosomal-Dominant Hypercholesterolemia Related to Mutations in<i>PCSK9</i> Khadija Ouguerram, Maud Chétiveaux, Yassine Zaïr, Arteriosclerosis Thrombosis and Vascular Biology	2004	180

Page 1